NCT02068690View on ClinicalTrials.gov

Safety, Tolerability, and Pharmacokinetics of Single Doses BI 425809

PHASE1CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Healthy
Interventions
DRUG

BI 425809 PfOS

BI 425809 PfOS

DRUG

Placebo

Placebo

DRUG

Placebo

Placebo

DRUG

BI 425809 tablet

BI 425809 tablet

DRUG

BI 425809 PfOS

BI 425809 PfOS

Trial Locations (1)

Unknown

1346.1.1 Boehringer Ingelheim Investigational Site, Ingelheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY